Data / Federal awards / NAICS 325412 / COHERUS ONCOLOGY, INC.
COHERUS ONCOLOGY, INC.: 3 federal contract awards, $11.8 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
COHERUS ONCOLOGY, INC. (UEI V13JDMAMELK8), Redwood City, CA, received 3 federal prime contract awards with $11.8 million obligated in fiscal years 2024 to 2027, from 2 agencies under 1 NAICS code. Its largest buyer is Department of Health and Human Services ($11.8 million) and its largest code is NAICS 325412 Pharmaceutical Preparation Manufacturing.
The request: Every federal contract awarded under NAICS 325412, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- V13JDMAMELK8UEI
- Redwood City, CALocation
- Small BusinessBusiness size
- 3Contract awards
- $11.8 millionObligated
- 2023-12-12First action in window
- 2026-07-06Latest action
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | 3 | $11.8 million |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 1 | $11.8 million |
| Department of Veterans Affairs | 2 | $0 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $0 |
| FY2025 | $11.8 million |
| FY2026 | $0 |
Contract awards
All 3 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75A50325C00002 | Department of Health and Human Services | Definitive Contract | 325412 | PEGFILGRASTIM 6MG/.06ML (INJ, SOLN, SYR OR AUTOINJECTOR) AND VMI | $11,805,200 | $11,805,200 | March 19, 2025 | March 18, 2030 | Redwood City, CA | usaspending.gov |
| 36E79725D0014 | Department of Veterans Affairs | IDC | 325412 | NEW AWARD FOR PEGFILGRASTIM WITH COHERUS BIOSCIENCES, INC. ORDERING PERIOD IS APRIL 11, 2025, TO APRIL 10, 2026, WITH FOUR ONE-YEAR OPTIONS. | $0 | $27,626,788 | April 11, 2025 | usaspending.gov | ||
| 36F79719D0216 | Department of Veterans Affairs | FSS | 325412 | 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | $0 | $9,023,352 | August 15, 2019 | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- Open opportunities under NAICS 325412
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.